<DOC>
	<DOCNO>NCT01714206</DOCNO>
	<brief_summary>The purpose study determine multiple dos canagliflozin ( JNJ-28431754 ) affect pharmacokinetics ( ie , body affect drug ) multiple dose digoxin . The safety tolerability canagliflozin also assess healthy volunteer .</brief_summary>
	<brief_title>A Study Assess Effects Canagliflozin ( JNJ-28431754 ) Pharmacokinetics Safety Digoxin Healthy Volunteers .</brief_title>
	<detailed_description>This study open label ( volunteer study staff know identity assign treatment ) , randomize ( treatment assign chance ) , multiple dose , cross-over study ( volunteer switch one treatment another ) determine canagliflozin ( drug currently investigate treatment type 2 diabetes mellitus ) affect pharmacokinetics digoxin ( drug use treat various heart condition ) . Volunteers randomly assign 1 2 treatment sequence group : Group AB Group BA . Volunteers assign Group AB give Treatment A : digoxin day 7 day . Volunteers assign Group BA give Treatment B : digoxin canagliflozin day 7 day . A washout period ( medication give ) least 14 day follow first 7-day treatment period . Following washout period , volunteer assign treatment receive first treatment period . This second treatment period last 7 day . Each volunteer participate study approximately 60 day .</detailed_description>
	<mesh_term>Digoxin</mesh_term>
	<mesh_term>Canagliflozin</mesh_term>
	<criteria>Volunteers must body mass index ( BMI = weight kg/height m2 ) 18 30 kg/m2 ( inclusive ) , body weight less 50 kg History , current active illness , consider clinically significant Investigator , illness Investigator considers exclude patient study , could interfere interpretation study result</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Healthy</keyword>
	<keyword>Canagliflozin ( JNJ-28431754 )</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Digoxin ( LANOXIN )</keyword>
</DOC>